Bryn Pharma announced it raised $26.7 Million in an amended filing from an offering of $30 Million

Company

Location

About

Bryn Pharma is a privately held pharmaceutical company based in North Carolina, focused on developing and commercializing innovative allergy treatments for managing anaphylaxis. Its mission is to empower patients with a life-saving device that fits comfortably in a pocket and is easy to use during an anaphylactic attack. The company’s intranasal delivery system offers a needle-free, portable, and affordable alternative to epinephrine auto-injectors.